In Vivo Phagocytosis Analysis of Amyloid Beta
Protocol
First Online:
- 4 Citations
- 7 Mentions
- 2.3k Downloads
Abstract
Alzheimer’s disease (AD) pathology is characterized by the presence of extracellular amyloid beta (Aβ), tau hyperphosphorylation, and neuroinflammation. One striking feature in the disease is the clustering of microglia around Aβ plaques. These cells exhibit a highly and chronically activated phenotype, performing a variety of functions, phagocytosis being one of them. Since Aβ phagocytosis by microglia could represent a key aspect in the pathogenesis and progression of the disease, robust and comprehensive methods to evaluate this process are needed. Here, we describe a detailed flow cytometry-based protocol for the analysis of Aβ phagocytosis in vivo.
Key words
Microglia Alzheimer’s disease Amyloid Phagocytosis Neurodegeneration Flow cytometryReferences
- 1.Winblad B, Amouyel P, Andrieu S et al (2016) Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455–532CrossRefGoogle Scholar
- 2.Sasaguri H, Nilsson P, Hashimoto S et al (2017) APP mouse models for Alzheimer’s disease preclinical studies. EMBO J 36:2473–2487CrossRefGoogle Scholar
- 3.Baruch K, Deczkowska A, Rosenzweig N et al (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer’s disease. Nat Med 22:135–137CrossRefGoogle Scholar
- 4.Heneka MT, Carson MJ, Khoury JE et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405CrossRefGoogle Scholar
- 5.Heneka MT, Kummer MP, Stutz A et al (2013) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493:674–678CrossRefGoogle Scholar
- 6.Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368:117–127CrossRefGoogle Scholar
- 7.Hollingworth P, Harold D, Sims R et al (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43:429–435CrossRefGoogle Scholar
- 8.Datta M, Staszewski O, Raschi E et al (2018) Histone deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner. Immunity 48:514–529.e6CrossRefGoogle Scholar
- 9.Keren-shaul H, Spinrad A, Weiner A et al (2017) Article a unique microglia type associated with restricting development of alzheimer ’ s disease article a unique microglia type associated with restricting development of alzheimer ’ s disease. Cell 169(7):1276–1290.e17CrossRefGoogle Scholar
- 10.Davalos D, Grutzendler J, Yang G et al (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758CrossRefGoogle Scholar
- 11.Hickman SE, Kingery ND, Ohsumi TK et al (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16:1896–1905CrossRefGoogle Scholar
- 12.Condello C, Yuan P, Schain A, Grutzendler J (2015) Microglia constitute a barrier that prevents neurotoxic protofibrillar abeta42 hotspots around plaques around plaques. Nat Commun 6:6176CrossRefGoogle Scholar
- 13.Lucin KM, O’Brien CE, Bieri G et al (2013) Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease. Neuron 79:873–886CrossRefGoogle Scholar
- 14.Paolicelli RC, Bolasco G, Pagani F et al (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–1458CrossRefGoogle Scholar
- 15.Czirr E, Castello NA, Mosher KI et al (2017) Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. J Exp Med 214(4):1081–1092CrossRefGoogle Scholar
- 16.Bradshaw EM, Chibnik LB, Keenan BT et al (2013) CD33 Alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16:848–850CrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC, part of Springer Nature 2019